Mary R. Doherty

687 total citations
7 papers, 500 citations indexed

About

Mary R. Doherty is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Mary R. Doherty has authored 7 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Mary R. Doherty's work include Cancer Cells and Metastasis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mary R. Doherty is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mary R. Doherty collaborates with scholars based in United States, Cameroon and Germany. Mary R. Doherty's co-authors include Damian J. Junk, Mark W. Jackson, Jacob Smigiel, George R. Stark, Arnold I. Caplan, Xia Liu, Alvaro G. Alvarado, Golam Kibria, Jeremy N. Rich and Stanton L. Gerson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Breast Cancer Research.

In The Last Decade

Mary R. Doherty

7 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary R. Doherty United States 5 318 262 151 95 40 7 500
Ahmed A. Quraishi United States 3 385 1.2× 281 1.1× 148 1.0× 102 1.1× 39 1.0× 4 529
Antonio Lucena-Cacace Spain 14 261 0.8× 365 1.4× 104 0.7× 47 0.5× 40 1.0× 23 598
Siti‐Faujiah Hendrayani Saudi Arabia 8 339 1.1× 267 1.0× 89 0.6× 128 1.3× 51 1.3× 8 532
Ruping Yan China 12 189 0.6× 365 1.4× 174 1.2× 92 1.0× 66 1.6× 22 559
Liliya Tyutyunyk‐Massey United States 10 170 0.5× 349 1.3× 105 0.7× 131 1.4× 48 1.2× 15 623
Kiyoung Eun South Korea 8 181 0.6× 258 1.0× 122 0.8× 45 0.5× 32 0.8× 16 395
Chaitanyananda B. Koppikar India 3 421 1.3× 390 1.5× 174 1.2× 69 0.7× 21 0.5× 3 645
Nader Tawakkol United States 2 369 1.2× 250 1.0× 134 0.9× 114 1.2× 44 1.1× 3 503
Dorcas A. Annan Japan 10 235 0.7× 320 1.2× 193 1.3× 180 1.9× 66 1.6× 14 574
Benjamin L. Bryson United States 12 287 0.9× 354 1.4× 150 1.0× 98 1.0× 79 2.0× 17 584

Countries citing papers authored by Mary R. Doherty

Since Specialization
Citations

This map shows the geographic impact of Mary R. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary R. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary R. Doherty more than expected).

Fields of papers citing papers by Mary R. Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary R. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary R. Doherty. The network helps show where Mary R. Doherty may publish in the future.

Co-authorship network of co-authors of Mary R. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Mary R. Doherty. A scholar is included among the top collaborators of Mary R. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary R. Doherty. Mary R. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Doherty, Mary R., Jessica R. Grant, Nils Pilotte, et al.. (2023). Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors. PLoS neglected tropical diseases. 17(12). e0011815–e0011815. 4 indexed citations
2.
Doherty, Mary R., Jenny G. Parvani, Ilaria Tamagno, et al.. (2019). The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer. Breast Cancer Research. 21(1). 54–54. 67 indexed citations
3.
Doherty, Mary R. & Mark W. Jackson. (2018). The Critical, Clinical Role of Interferon-Beta in Regulating Cancer Stem Cell Properties in Triple-Negative Breast Cancer. DNA and Cell Biology. 37(6). 513–516. 14 indexed citations
4.
Doherty, Mary R., Damian J. Junk, HyeonJoo Cheon, George R. Stark, & Mark W. Jackson. (2017). Abstract 2884: Interferon Beta (IFN-B) re-activates canonical type I IFN signaling to differentiate breast cancer stem cells (CSCs) and suppress mesenchymal/CSC driven tumor recurrence. Cancer Research. 77(13_Supplement). 2884–2884. 1 indexed citations
5.
Doherty, Mary R., Damian J. Junk, Shaveta Vinayak, et al.. (2017). Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proceedings of the National Academy of Sciences. 114(52). 13792–13797. 96 indexed citations
6.
Doherty, Mary R., Jacob Smigiel, Damian J. Junk, & Mark W. Jackson. (2016). Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers. 8(1). 8–8. 118 indexed citations
7.
Adorno-Cruz, Valery, Golam Kibria, Xia Liu, et al.. (2015). Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance. Cancer Research. 75(6). 924–929. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026